Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fura Gems Inc. stock logo
FURA
Fura Gems
C$0.15
-3.3%
C$0.14
C$0.05
C$0.21
C$39.45M1.06128,388 shs10,000 shs
Hannan Metals Ltd. stock logo
HAN
Hannan Metals
C$0.41
+3.8%
C$0.28
C$0.14
C$0.45
C$44.86M0.6569,959 shs21,000 shs
MMV
MultiMetaVerse
$0.66
-5.7%
$0.89
$0.61
$4.00
$4.03M0.1860,870 shs10,636 shs
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$0.08
$0.12
$0.07
$1.42
$2.79M1.973.40 million shs916,801 shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fura Gems Inc. stock logo
FURA
Fura Gems
0.00%0.00%0.00%0.00%0.00%
Hannan Metals Ltd. stock logo
HAN
Hannan Metals
-10.23%+3.95%-5.95%+132.35%+61.22%
MMV
MultiMetaVerse
+2.56%-12.50%-19.08%-32.69%+69,999,900.00%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
+3.68%-3.43%-44.20%-50.84%+7,599,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AN/AN/AN/AN/AN/AN/A
Hannan Metals Ltd. stock logo
HAN
Hannan Metals
N/AN/AN/AN/AN/AN/AN/AN/A
MMV
MultiMetaVerse
N/AN/AN/AN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AN/AN/A
Hannan Metals Ltd. stock logo
HAN
Hannan Metals
N/AN/AN/AN/A
MMV
MultiMetaVerse
N/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AC$0.01 per share29.00C$0.02 per shareN/A
Hannan Metals Ltd. stock logo
HAN
Hannan Metals
N/AN/AC$0.02 per share20.67C$0.10 per shareN/A
MMV
MultiMetaVerse
N/AN/AN/AN/A($1.06) per shareN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$14.73M0.19N/AN/A$0.12 per share0.64

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fura Gems Inc. stock logo
FURA
Fura Gems
-C$29.04M-C$0.12N/AN/AN/A-495.84%-38.02%N/A
Hannan Metals Ltd. stock logo
HAN
Hannan Metals
-C$2.65M-C$0.03N/AN/AN/A-25.00%-14.90%N/A
MMV
MultiMetaVerse
-$2.25MN/A0.00N/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
-$9.64M-$3.82N/A1.10N/A-65.46%-150.14%-53.48%N/A

Latest HAN, FURA, MMV, and NBY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/26/2024Q4 2023
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A-$0.95-$0.95-$0.57N/A$3.73 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AN/AN/AN/A
Hannan Metals Ltd. stock logo
HAN
Hannan Metals
N/AN/AN/AN/AN/A
MMV
MultiMetaVerse
N/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fura Gems Inc. stock logo
FURA
Fura Gems
1,870.18
0.26
0.12
Hannan Metals Ltd. stock logo
HAN
Hannan Metals
3.59
4.73
5.40
MMV
MultiMetaVerse
N/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A
1.67
1.00

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Fura Gems Inc. stock logo
FURA
Fura Gems
N/A
Hannan Metals Ltd. stock logo
HAN
Hannan Metals
N/A
MMV
MultiMetaVerse
N/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
23.25%

Insider Ownership

CompanyInsider Ownership
Fura Gems Inc. stock logo
FURA
Fura Gems
65.00%
Hannan Metals Ltd. stock logo
HAN
Hannan Metals
11.99%
MMV
MultiMetaVerse
29.00%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
1.30%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Fura Gems Inc. stock logo
FURA
Fura Gems
N/A272.04 millionN/ANot Optionable
Hannan Metals Ltd. stock logo
HAN
Hannan Metals
N/A109.41 millionN/ANot Optionable
MMV
MultiMetaVerse
2076.10 million4.33 millionNot Optionable
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
2436.06 million35.59 millionNot Optionable

HAN, FURA, MMV, and NBY Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Fura Gems logo

Fura Gems

CVE:FURA
Fura Gems Inc., a gemstone mining and marketing company, engages in the mining, exploration and acquisition of gemstone licenses in Barbados, the British Virgin Islands, Colombia, Dubai, India, Mozambique, Madagascar, and Australia. It holds a 100% interests in four ruby licenses in the Montepuez district of Cabo Delgado province in Mozambique; and a 76% interests in the Coscuez license that covers an area of covers an area of 46 hectares in San Pablo de Borbur, Boyacá District of Colombia. The company also holds a 100% interests in two mining permits and three mining licenses in the sapphire mining project located in Queensland, Australia; and owns sapphire licenses in Madagascar. The company was formerly known as Fura Emeralds Inc. and changed its name to Fura Gems Inc. in April 2017. Fura Gems Inc. was incorporated in 2006 and is headquartered in Toronto, Canada. Fura Gems Inc. operates as a subsidiary of Lord of Seven Hills Holdings FZE.
Hannan Metals logo

Hannan Metals

CVE:HAN
Hannan Metals Ltd., a junior mineral exploration company, engages in the acquisition and exploration of mineral properties in Ireland and Peru. The company explores for copper, gold, silver, zinc, and lead deposits. Its flagship project is the 100% owned the San Martin project covering an area of 65,600 hectares located to the northwest of Tarapoto, Peru. The company was formerly known as Mitchell Resources Ltd. and changed its name to Hannan Metals Ltd. in January 2017. Hannan Metals Ltd. is based in Vancouver, Canada.

MultiMetaVerse

NASDAQ:MMV
MultiMetaVerse Holdings Limited operates as an animation and entertainment company in the People's Republic of China. It offers a product portfolio, including animated content, comic books, short videos, collectibles, stationery, consumer products, and mobile games under the Aotu World brand, as well as action figures, stuffed dolls, apparel, costumes, trading cards, and other collectibles and functional items. The company also creates and operates proprietary brand and animation series; develops and operates apps; and animation production services to animation, gaming, and other entertainment companies. In addition, it sells merchandises, such as animation collectibles, books, stationery, apparel, plush toys, and other commercial appealing products through its proprietary storefront on online vendor platforms, such as Tmall.com and Taobao.com, as well as through distributors; and grants third party license rights to develop and market merchandise. The company also provides animation production services to other animation and gaming companies. MultiMetaVerse Holdings Limited was founded in 2015 and is headquartered in Shanghai, the People's Republic of China.
NovaBay Pharmaceuticals logo

NovaBay Pharmaceuticals

NYSE:NBY
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.